[1] Riggin A, Luu VT, Lobdell JK, et al. A non-isotopic probe-hybridization assay for residual DNA in biopharmaceuticals [J]. J Pharm Biomed Anal, 1997, 12 : 561-572. [2] Rathore AS, Sobacke SE, Kocot TJ, et al. Analysis for residual host cell proteins and DNA in process streams of a recombinant protein product expressed in Escherichia coli cells [J]. J Pharm Biomed Anal, 2003, 8 : 1199-1211. [3] Lupker JH. Residual host cell protein from continuous cell lines : effect on the safety of protein pharmaceuticals [J]. Dev Bio Stand, 1998, 1 : 61-64. [4] Zhou HJ. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) [M]. Beijing : People’s Health Publishing House, 2000. 31-52. [5] Bradford MM. A novel method for protein estimation assay using brilliant blue G [J]. Anal Biochem, 1976, 72 : 248. [6] Bradford Reagent, Technical Bulletion [S], Sigma Product Information, 2000. [7] Hu CQ, Jin SH,Wang KW. The chromatographic behaviour of cephalosporins in gel filtration chromatography, a novel method to separate high molecular weight impurities [J]. J Pharm Biomed Anal, 1994, 12 : 533-541. [8] Cai SY, Hu CQ,Xu MZ. Evaluation of measurement methods for high molecular weight impurities in amoxicillin [J]. J Pharm Biomed Anal, 2003, 31 (3) : 589-596. |